Selective control of enzyme activity is critical for elucidating the roles of specific proteins in signaling pathways. One potential means for developing truly target-specific inhibitors involves the use of protein engineering to sensitize a target enzyme to inhibition by a small molecule that does not inhibit homologous wild-type enzymes. Previously, it has been shown that protein tyrosine phosphatases (PTPs) can be sensitized to inhibition by a biarsenical probe, FlAsH-EDT 2 , which inhibits PTP activity by specifically binding to cysteine residues that have been introduced into catalytically important regions. In the present study, we developed an array of biarsenical probes, some newly synthesized and some previously reported, to investigate for the first time the structure-activity relationships for PTP inhibition by biarsenicals. Our data show that biarsenical probes which contain substitutions at the 2′ and 7′ positions are more effective than FlAsH-EDT 2 at inhibiting sensitized PTPs. The increased potency of 2′,7′-substituted probes was observed when PTPs were assayed with both para-nitrophenylphosphate and phosphopeptide PTP substrates and at multiple probe concentrations. The data further indicate that the enhanced inhibitory properties are the result of increased binding affinity between the 2′,7′-substituted biarsenical probes and sensitized PTPs. In addition we provide previously unknown physicochemical and stability data for various biarsenical probes.
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Introduction
Selective control of the activity of a single enzyme is a key criterion for chemical-biology strategies that aim to unravel a target enzyme's physiological and/or pathological functions in the cell. Chemical control of enzyme activity is most frequently achieved with smallmolecule inhibitors, which can either interact with a target enzyme's active site or block its activity by allostery. However, it is often very difficult to design a cell-permeable small molecule that is specific only toward a target enzyme, particularly if the enzyme is a member of a large protein family. A complementary approach for achieving target-specific inhibition of an enzyme involves sensitizing the enzyme of interest toward a selected molecule that does not inhibit the wild-type enzyme or other homologous proteins. 1, 2, 3 In a successful sensitization strategy, which requires engineering of the enzyme to introduce a binding site for the inhibitor, suppression of enzyme activity is target-specific, a feature that is especially desirable in cell-signaling studies.
The classical protein tyrosine phosphatases (PTPs) are a large family of enzymes that catalyze the dephosphorylation of phosphotyrosine in metazoan signaling networks. Because the PTPs share a highly conserved active site and because many known inhibitors of wildtype PTPs are not cell-permeable, 4 this protein family potentially presents an ideal case for sensitization strategies. Previous studies on PTP sensitization have shown that introduction of spatially arranged cysteine residues into a loop of a PTP domain is sufficient to confer strong affinity for the membrane-permeable biarsenical probe, FlAsH-EDT 2 , initially designed to specifically visualize proteins in the cell. 5, 6, 7, 8 Binding of FlAsH-EDT 2 to the sensitized PTP can cause strong inhibition of PTP activity, which relies on the specific conjugation of the compound's two arsenic atoms with the cysteine-rich motif that is incorporated into the target PTP (Fig. 1A) . The activities of wild-type PTPs, therefore, are generally unaffected by FlAsH-EDT 2 .
An array of sensitized T-cell PTP (TCPTP) mutants, which contain tetracysteine (TC) motifs inserted at various loops within the enzyme's PTP domain, has been previously developed. 5 These TCPTP mutants exhibited varying degrees of inhibition by FlAsH-EDT 2 , the most highly sensitive being a construct in which the tetracysteine insertion was placed directly adjacent to the PTP domain's WPD loop (4C@187 TCPTP). 6 The opening and closing of the conserved WPD loop is critical for the activity of all classical PTPs, 9, 10 and it was hypothesized that FlAsH-EDT 2 inhibits 4C@187 TCPTP by rigidifying its WPD-loop's local structure and disrupting its normal dynamics. Subsequent studies showed that TCPTP mutants with two or three cysteines placed within the WPD loop could also be potently inhibited by FlAsH-EDT 2 . 6 Work to date on PTP sensitization has focused solely on the optimization of protein engineering, using only FlAsH-EDT 2 as the inhibitory biarsenical compound. Since multiple types of biarsenical probes with differing structures and physicochemical properties have been reported 11 we aimed to obtain a library of biarsenical probes, composed of both known and novel compounds, to test the probes' abilities to act as inhibitors of sensitized PTPs. We hypothesized that screening an array of probes with previously engineered PTP mutants would allow for the identification of optimized biarsenical/enzyme pairs, in which the degree of engineered PTP inhibition is maximized. In the course of these studies we also made unexpected observations concerning the differing stabilities of biarsenical probes in solution;
these findings, also reported here, will be of utility to the entire biarsenical-research community.
Results and discussion
Synthesis of biarsenical probes
The biarsenical probes used in this study were prepared based on resorufin, fluorescein, and seven fluorescein derivatives. This library includes both new (Et2FlAsH-EDT 2 , Cl4FlAsH-EDT 2 , and 5-Bu-CrAsH-EDT 2 ) and previously described compounds (Fig. 2) 16, 17 . Although the dimercury synthetic intermediates were obtained for both hexa-halogen fluorophores, the subsequent transmetalation was not successful, despite several attempts (data not shown).
Physicochemical characterization of biarsenical probes
Since a full complement of physicochemical data for our library of biarsenical probes has not been reported, we performed a systematic analysis of the probes in complex with an optimized tetracysteine peptide (TC12), 20 the results of which are summarized in Table 1 . The full set of spectra can be found in Figure S2 (ESI †). The characterization data are in good agreement with previously published results (where available), with one exception: our absorbance (510 nm) and emission (530 nm) maxima wavelengths for the F2FlAsH−TC12 complex are higher than previously reported values by 10 and 8 nm, respectively. 14 We suspect that, since experimental conditions (pH and tetracysteine peptide) are essentially identical for the differing measurements, the discrepancy may be due to the significant degradation of the F2FlAsH-EDT 2 used in the previous study. F2FlAsH's corresponding monoarsenical species, has an absorbance maximum of 500 nm (Fig. S3 , ESI †), 20 and we observed that DMSO solutions of 2′,7′-substituted probes (Cl2FlAsH-EDT 2 , Et2FlAsH-EDT 2 and F2FlAsH-EDT 2 ) degrade significantly when stored as DMSO solution overnight at -20 °C (see below for further discussion of biarsenical stability).
Next, we determined the pK a values for the 3′-phenolic groups of the biarsenical probes in the library. Although proton dissociation from 3′-phenol is required for the fluorescent properties of fluorescein and resorufin derivatives, and pK a values are highly sensitive reporters of the electron rich/poor character of a particular functional group, the pK a values for almost all of the library's probe−peptide complexes have not been previously reported. Our systematic acid-base study shows that in every case the biarsenical probe−peptide complex has a lower phenolic pK a value than the parent fluorophore ( Table 1 ).
The highest acidity of the phenolic group is observed for Cl2FlAsH-TC12 and F2FlAsH-TC12 complexes due to the high electronegativity of the halogen substituents. These probes demonstrate stable fluorescence properties over a broad pH range, potentially enabling their use in staining tetracysteine-tagged proteins in a variety of cellular compartments, including lysosomes. Interestingly, in the biarsenical complexes containing TC12 peptide, a second dissociation event with a pK a value of ~7 is also observed (Fig. S4, 
Stability of biarsenical probes
The main route of biarsenical probe degradation in aqueous solution is the breaking of As-C bond, forming monoarsenical species and subsequently the parent fluorophore, exemplified by mass spectra of decomposed Et2FlAsH (Fig. S6 , ESI †). However, the extent or timeline of this process has not been precisely measured in previous studies. Experiments with inhibition of sensitized PTP with biarsenical probe include a 2.5 h pre-incubation of enzyme with biarsenical probe (vide infra). We therefore tested whether significant amounts of monoarsenical species would be formed under these conditions, as significant degradation of the biarsenicals would, of course, alter the outcome of the inhibition experiments. Using analytical HPLC we determined that most of the probes do not degrade in significant amounts ( Fig. 5 and Table S1 , ESI †). For example, a 6 h incubation gave rise to only a 0.92% increase of monoarsenical FlAsH-EDT and a 0.42% increase in monoarsenical F4FlAsH-EDT . By contrast, the extent of hydrolysis was significant for Et2FlAsH-EDT 2 , which showed a 14.2%
increase in monoarsenical species after 6 h. We also observed that, although all of the biarsenical probes described here can be stored in solid form for prolonged times without degradation, DMSO stock solutions may degrade overnight, even when kept at -20°C, as we observed for Cl2FlAsH-EDT 2 , Et2FlAsH-EDT 2 and F2FlAsH-EDT 2 (data not shown).
Inhibition of PTP activities by biarsenical probes
In order to assess the PTP-inhibitory activity for the library of biarsenical probes we expressed and purified both wild-type and engineered variants of two PTPs: T-cell PTP (TCPTP) and hematopoietic PTP (HePTP). The PTP set included four mutants of TCPTP and one of HePTP ( Figure 1 ), all of which have been previously described. 5, 6, 7 We chose TCPTP because the previously published optimization of localization of biarsenical-binding cysteines was performed on this enzyme; HePTP was also used to confirm that the results can be An initial screen of the seven PTPs (2 wild-type, 5 engineered) and nine biarsenical probes (63 PTP-probe combinations) was carried out with the small-molecule PTP substrate para-nitrophenylphosphate (pNPP) in the presence of 20 µM TCEP. 24 We used TCEP instead of DTT, since the latter can compete with tetracysteine motifs for binding of biarsenical probes. 15 TCEP has also been previously used in PTP assays, 25 and a lack of this reducing agent causes a decrease of enzyme activity during 2.5 h incubation at room temperature, see F2FlAsH-EDT 2 not only inhibits the enzyme to higher extent at a 4:1 ratio of biarsenical probe to protein but also has 14-(P181C+2C) and 9-fold (4C) higher affinities toward the target PTPs (Table 2) . These values corroborate results obtained using pNPP as a substrate, showing that improved inhibition is substrate-independent, as would be expected if the biarsenical dye blocks the conformational changes of the WPD loop that are required for catalysis. 9,10 Since Et2FlAsH-EDT 2 also provided improved reduction of catalytic efficiency, the molecular basis can be explained with two factors. First, the 2',7'-substituted biarsenical probes can potentially induce steric hindrance during closing of the WPD loop, due to the sheer size of the compounds. Second, the presence of halogen atoms may result in the increased Lewis acidity of the compounds' arsenic atoms, thereby increasing the stability of binding with the engineered cysteine residues of the target proteins.
Collectively, our results based on both pNPP and phosphopeptide assays confirm that cysteine-enriched WPD loops can be effectively targeted and that substantial improvements in inhibition can be realized by using optimized biarsenical probes.
Conclusions
In conclusion, we have developed a library of known and new biarsenical probes and systematically characterized their physicochemical properties, many of which were previously unknown. In the course of these studies we found that some biarsenical probes are 
Experimental procedures Materials
Unless otherwise noted, all chemicals and reagents were obtained from commercial suppliers Biotech were dried and stored over 3Å molecular sieve.
Synthesis of biarsenical probes
The biarsenical probes used in this study were prepared based on a general synthesis protocol published previously. least 95% purity, as estimated by HPLC described below, were collected. The pooled fractions were concentrated on a rotary evaporator, aliquoted, and dried by Speed Vac. Once solvent was evaporated, tubes were immediately removed to avoid degradation by overdrying. 27 Because of that solid contained small amounts of solvents used during purification, which prohibited the estimation of the synthesis yield of biarsenical derivatives. Identification and purity assessment of the fractions and final product were carried out on by ESI-MS (Applied Biosystems API 2000) and HPLC (Dionex Ultimate 3000 using a Phenomenex Aeris Peptide C18 column, see ESI † for details). All biarsenical probes were stored as solid in -20ºC. Prior to use probes were dissolved in anhydrous DMSO.
4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (FlAsH-EDT 2 ).
An orange solid was obtained. Analysis on HPLC (Phenomenex Aeris Peptide 3.6 µm C 18 ): t R = 14.9 min. with gradient from 100 : 0 to 10 : 90 (5 mM NH 4 CO 3 : ACN) in 20 min.
showed purity of 99 %. 
2',7'-difluoro-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (F2FlAsH-EDT 2 ).
An orange solid was obtained. 
2',7'-dichloro-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (Cl2FlAsH-EDT 2 ).
A red solid was obtained. 
2',7'-diethyl-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (Et2FlAsH-EDT 2 ).
4,5,6,7-tetrachloro-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (F4FlAsH-EDT 2 ).
4,5,6,7-tetrachloro-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (Cl4FlAsH-EDT 2 ).
5-Carboxy-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (5-CrAsH-EDT 2 ).
An orange solid was obtained. Analysis on HPLC (Phenomenex Aeris Peptide 3.6 µm C 18 ): 
5-(N-butylamide)-4',5'-bis(1,3,2-dithiarsolan-2-yl)-fluorescein (5-BuCrAsH-EDT 2 ).
An 
4,5-Bis(1,3,2-dithiarosolan-2-yl)-resorufin (ReAsH-EDT 2 ).
An orange solid was obtained. Analysis on HPLC (Phenomenex Aeris Peptide 3.6 µm C 18 ): t R = 13.3 min. with gradient from 100 : 0 to 10 : 90 (5 mM NH 4 CO 3 : ACN) in 20 min.
showed purity of 97 %. 
Peptide synthesis
Tetracysteine peptides Ac-FLNCCPGCCMEP-amide (TC12) and Ac-CCPGCC-amide (TC6)
were synthesized by solid phase synthesis using the Fmoc strategy. Tenta Gel R Ram resin was utilized for amide peptides and 2-chlorotrityl for carboxyl peptides. Peptides were synthesized in Liberty 1 microwave-assisted synthesizer (CEM). Couplings of amino acids were performed with 3 eq. of N-α-Fmoc-protected amino acid, HBTU (3 eq.) and DIEA (5 eq.) in DMF. Peptides were terminated by acetylation with Ac 2 O. For that purpose resin was mixed with 4 eq. of Ac 2 O, 4 eq. of DIEA in DMF for 4 h. Peptide cleavage was achieved with mixture of 90% of TFA, 5% thioanisole, 3% anisole and 2% 1,2-ethanedithiol over 1.5
h, followed by precipitation in cold (-80°C) diethyl ether. Crude peptide pellets were collected by centrifugation. Peptides were purified on HPLC (Dionex Ultimate 3000) using semi-preparative Phenomenex Gemini-NX C18 column and gradient of 0.1% TFA in acetonitrile with 0.1% TFA. The purified peptide was identified by ESI mass spectrometry using API 2000 (Applied Biosystems) instrument. MS (m/z) calculated for TC12 and TC6
[M+H] + were 1358.7, 626.8 and found 1358.4, 626.6, respectively.
Physicochemical properties of biarsenical probes
Electronic spectra were obtained on a Jasco V-650 spectrophotometer. 
Determination of pK a values.
Solutions containing 1 µM biarsenical probe with 6 µM TC12 peptide in 50 mM Na + -borate buffer with 50 µM TCEP at pH 10.0 were incubated at room temperature until no increase of fluorescence was observed. Samples were then titrated with HCl, and the resulting and pH and fluorescence intensities were measured and fitted using Hill's equation (Eq. S1, ESI †) in order to obtain pK a values and Hill coefficients for the phenolic group at position 3′. When TC6 peptide was used the same methodology was applied and data was fitted to Hill's equation (Eq. S2, ESI †)
Stability of biarsenical probes.
Solutions of 25 µM biarsenical probes in 50 mM Na + -HEPES buffer and 100 mM NaCl at pH 7.4 were incubated in darkness over periods of 1, 2, 3 or 6 h and analyzed by analytical HPLC (Dionex Ultimate 3000 using column C18 Phenomenex Aeris Peptide) using a 5 mM ammonium carbonate/acetonitrile gradient. Since monoarsenical and biarsenical species have absorption maxima that differ by ~10 nm, the percent composition of the two species was estimated by comparing the peak areas from chromatograms collected at 280 nm.
Protein expression and purification
Plasmids encoding the wild-type and mutant forms of six-histidine tagged TCPTP and HePTP were described previously (see Table 2 for mutant amino-acid sequences). [5] [6] [7] The appropriate plasmids were used to transform BL21(DE3)-codonPLUS-RIL E. coli. Single colonies were picked and used to inoculate 1000 ml LB cultures, which were grown to midlog phase at 37°C, and induced with either 0.2 mM IPTG (TCPTP) or 0.04% arabinose or 8, prepared as described above. All experiments were performed in triplicates. biarsenical probes were incubated for 1, 3 and 6 h in 50 mM Na+-HEPES buffer, 100 mM NaCl, pH 7.4. The percentage of monoarsenical species was determined using analytical HPLC. Details can be found in Table S1 (ESI †). 
Graphical abstract
A library of biarsenical probes was developed, characterized and used to probe structureactivity relationships for inhibition of sensitized protein tyrosine phosphatases (PTPs), revealing the superior inhibitory properties of 2'7'-substituted biarsenicals.
